Suppression of lymphocyte proliferation by a retroviral p15E‐derived hexapeptide

CKS‐17 (LQNRRGLDLLFLKEGGL), a synthetic peptide derived from a conserved region of retroviral transmembrane proteins, has previously been shown to suppress severaldifferent immune effector mechanisms. The present study was undertaken to further delineate immunosuppressive site(s) of CKS‐17. Overlapping hexapeptides covering the complete sequence of CKS‐17 were synthesized. One CKS‐17‐derived hexapeptide, LDLLFL, suppressed ligand [CD3, interleukin (IL)‐2]‐induced lymphocyte proliferation. Spontaneous proliferation of transformed lymphoid cell lines, as well as cell lines from myeloid or epitheloid origin, was not inhibited byLDLLFL. Full suppression required the continuous presence of LDLLFL during culturing, and did not involve interference with monocyte function. Radiolabeling studies showed that the hexapeptide did not compete with IL‐2 for IL‐2 receptor binding. Most likely the LDLLFL motif inteferes with steps shared bythe IL‐2 and CD3 receptor‐induced signaling pathways. Since LDLLFL displays multiple immunosuppressive activities, it may constitute a biologically relevant immunosuppressive site of retroviral transmembrane proteins.